Cited by 76Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsMedical Imaging Techniques and Applications

18Fluorodeoxyglucose Positron Emission Tomography Studies in Presumed Alzheimer Cases, Including 13 Serial Scans

Open access
McGeer, E.G., Peppard, R.P., McGeer, P.L., Tuokko, H., Crockett, D., Parks, R., Akiyama, H., Calne, D.B. +2 more·1990·Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

Abstract

Positron emission tomographic (PET) data on local cerebral metabolic rates for glucose (LCMR) are reported for 32 regions of interest (ROI)s in cross-sectional studies on 57 patients with clinically diagnosed Alzheimer's disease (AD) and 20 neurologically normal controls, and in serial studies on 13 of the AD cases, including a familial, young-onset case where the diagnosis has been confirmed at autopsy. Extensive psychological testing was done on all the AD cases. Almost all cortical regions showed a significant decline in LCMR with age in the control subjects. There were the expected cortical metabolic deficits in AD and the serial studies showed a general increase in such deficits over time in 12 of the 13 cases. The regions showing the greatest declines with time in serial studies are the same as those showing the most severe deficiencies in cross-sectional studies. The young-onset case did not show a greater rate of metabolic decline than many of the older cases studied. Results on individual psychological tests tended to correlate with metabolic rates in multiple, rather than single, cortical regions, suggesting intact neuronal networks are required for good performance. The correlations with cortical metabolic activity found were of a sign indicating that the higher the metabolic rates and the better the left:right asymmetry index, the better was the performance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s0317167100029930

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Frackowiak RSJ. Cerebral energy metabolism and blood flow in normal human ageing: a short review. Circulation et Metabolism du Cerveau 1987; 4: 87-92.
  2. Szelies B, Herholz K, Pawlik G, et al. Cerebral glucose metabolism in presenile dementia (Alzheimer's disease) -follow-up under treatment course with a muscarinic choline agonist. Fortschr Neurol Psychiatry 1986; 54: 364-373.

Cited by

Sorted by citations

Authors
McGeer, E. G., Peppard, R. P., McGeer, P. L., Tuokko, H., Crockett, D., Parks, R., Akiyama, H., Calne, D. B., Beattie, B. L., & Harrop, R.
Affiliations
  • University of British Columbia (CA)
  • Simon Fraser University (CA)
Corresponding author
McGeer, E.G.
Venue
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Published
1990-02
Volume
17
Issue
1
Pages
1-11
ISSN
  • 0317-1671 (ISSN-L)
  • 2057-0155
OpenAlex
W2411997763
Cited by
76
References
30
Citations by year
2018: 2 · 2017: 1 · 2016: 1 · 2014: 1 · 2013: 2 · 2012: 3
FWCI
3.42
Type
journal article
Language
en
Open access
Locations
  • Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Alzheimer Society
  • Medical Research Council Canada
  • Medical Research Council
  • Alzheimer Society of B.C.
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
Alzheimer's disease, 18F-FDG PET, early-onset Alzheimer's disease, familial Alzheimer's disease, neuropsychological performance, hemispheric lateralization, age-related metabolic decline
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Brain, Cerebral Cortex, Deoxy Sugars, Deoxyglucose, Female, Fluorine Radioisotopes, Humans, Male, Middle Aged, Psychological Tests, Tomography, Emission-Computed, Fluorodeoxyglucose F18

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review